Search research articles
Contact Us
Filters
Showing results (81-90 of 108) with videos related to
Page
of 11
Sort By:
Nanomaterials (Basel, Switzerland)
|
March 29, 2023
Insights into the Photoelectrocatalytic Behavior of gCN-Based Anode Materials Supported on Ni Foams
Serge Benedoue, Mattia Benedet, Alberto Gasparotto, et al.
The European Respiratory Journal
|
October 7, 2017
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD
Marco Contoli, Alessia Pauletti, Maria Rita Rossi, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 23, 2021
Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and β<sub>2</sub> agonist (MABA) for the treatment of chronic obstructive pulmonary disease (COPD)
Fabio Rancati, Ian D Linney, Andrea Rizzi, et al.
Bioorganic & Medicinal Chemistry
|
April 24, 2010
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: Synthesis and evaluation of their phosphodiesterase 4 inhibitory activity
Pierfrancesco Biagini, Claudio Biancalani, Alessia Graziano, et al.
Journal of Chemical Theory and Computation
|
October 24, 2018
Escaping Atom Types in Force Fields Using Direct Chemical Perception
David L Mobley, Caitlin C Bannan, Andrea Rizzi, et al.
Gland Surgery
|
February 11, 2026
Implantation of cancer cells from transoral endoscopic thyroidectomy: a case report
Daqi Zhang, Hui Sun, Matteo Annoni, et al.
Living Journal of Computational Molecular Science
|
August 30, 2021
Best Practices for Alchemical Free Energy Calculations [Article v1.0]
Antonia S J S Mey, Bryce K Allen, Hannah E Bruce Macdonald, et al.
Journal of Computer-Aided Molecular Design
|
January 28, 2020
The SAMPL6 SAMPLing challenge: assessing the reliability and efficiency of binding free energy calculations
Andrea Rizzi, Travis Jensen, David R Slochower, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 11, 2015
CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration
Nadia Moretto, Paola Caruso, Raffaella Bosco, et al.
Journal of Medicinal Chemistry
|
June 10, 2024
Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β<sub>2</sub> Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases
Laura Carzaniga, Ian D Linney, Andrea Rizzi, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 108) with videos related to
Sort By:
Page
of 11
Nanomaterials (Basel, Switzerland)
|
March 29, 2023
Insights into the Photoelectrocatalytic Behavior of gCN-Based Anode Materials Supported on Ni Foams
Serge Benedoue, Mattia Benedet, Alberto Gasparotto, et al.
The European Respiratory Journal
|
October 7, 2017
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD
Marco Contoli, Alessia Pauletti, Maria Rita Rossi, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 23, 2021
Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and β<sub>2</sub> agonist (MABA) for the treatment of chronic obstructive pulmonary disease (COPD)
Fabio Rancati, Ian D Linney, Andrea Rizzi, et al.
Bioorganic & Medicinal Chemistry
|
April 24, 2010
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: Synthesis and evaluation of their phosphodiesterase 4 inhibitory activity
Pierfrancesco Biagini, Claudio Biancalani, Alessia Graziano, et al.
Journal of Chemical Theory and Computation
|
October 24, 2018
Escaping Atom Types in Force Fields Using Direct Chemical Perception
David L Mobley, Caitlin C Bannan, Andrea Rizzi, et al.
Gland Surgery
|
February 11, 2026
Implantation of cancer cells from transoral endoscopic thyroidectomy: a case report
Daqi Zhang, Hui Sun, Matteo Annoni, et al.
Living Journal of Computational Molecular Science
|
August 30, 2021
Best Practices for Alchemical Free Energy Calculations [Article v1.0]
Antonia S J S Mey, Bryce K Allen, Hannah E Bruce Macdonald, et al.
Journal of Computer-Aided Molecular Design
|
January 28, 2020
The SAMPL6 SAMPLing challenge: assessing the reliability and efficiency of binding free energy calculations
Andrea Rizzi, Travis Jensen, David R Slochower, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 11, 2015
CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration
Nadia Moretto, Paola Caruso, Raffaella Bosco, et al.
Journal of Medicinal Chemistry
|
June 10, 2024
Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β<sub>2</sub> Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases
Laura Carzaniga, Ian D Linney, Andrea Rizzi, et al.
Page
of 11